NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model

Data ReadoutpositiveExoPTENPositive

AI Analysis

Summary

NurExone reported preclinical tissue-analysis data showing ExoPTEN treatment resulted in significantly higher numbers of myelin-positive cells compared to controls in an acute spinal cord injury animal model, supporting potential neuroprotective effects.

Clinical Trial Data

Phase

preclinical

Primary Endpoint

Met

Outcome Details

Tissue analysis showed significantly higher numbers of myelin-positive cells in ExoPTEN-treated animals compared with controls

Importance:4/10

Sentiment:

0.60

preclinicalspinal cord injuryneuroprotectionmyelintissue analysisanimal model

Related Companies

$MEHA

Read the original article

Published by GlobeNewswire Clinical Studies on August 14, 2026 12:59 PM

Read Original